Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases
- 17 August 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 151 (2) , 506-507
- https://doi.org/10.1111/j.1365-2133.2004.06107.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximabJournal of the American Academy of Dermatology, 2002
- Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitorsAnnals of the Rheumatic Diseases, 2002
- Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialThe Lancet, 2000
- Autoimmune Skin Rashes Associated with Etanercept for Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Response to tumor necrosis factor in two cases of psoriasisJournal of the American Academy of Dermatology, 1991
- Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasisBritish Journal of Dermatology, 1991